ZGNX – Zoegenix, Inc is a pharmaceutical company which develops and commercializes therapies to treat disorders pertaining to the central nervous system.
ZGNX – Zoegenix, Inc
|Fundamentals||Previously closed at||9.81|
|Analysts opinion||Recently many firms including Opaleye Management Inc, RA Capital Management LLC have bought stakes in Zoegenix. Also, Brean Capital has reiterated a buy rating with a Price target of $28.00, which is a ~300% upside! Though the Q1 results for the company was a loss, the company topped analyst expectations. Confidence meter, a proprietary algorithm of Stockal is 83% positive.|
|Sentiments||The Sentiment Index, a proprietary algorithm of Stockal, reads a 50% positive sentiments.|
|Social Media Pulse||The stock has 3% lower social media chatter than usual.|